Revolucionando a Medicina Genômica
Mendelics (mendelics.com.br) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Technology brands, in the 70th percentile of 12113 Healthcare brands.
Mendelics is a Brazilian laboratory founded in 2012, based in São Paulo, specializing in genomic analysis. Described as the first and largest genomics-focused laboratory in Latin America, it offers advanced genetic tests including exome sequencing, recessive disease screening, and hereditary cancer testing. Its stated mission is to revolutionize medicine through precise and accessible genetic diagnostics, serving patients, families, and healthcare professionals seeking diagnosis, prevention, and treatment of hereditary diseases and cancer.
| Brand Name | Mendelics |
|---|---|
| Domain | mendelics.com.br |
| Industry | Healthcare, Technology |
| Founded | 2012 |
| Headquarters | São Paulo, Brazil |
| Main Competitors | DASA (80/100), Fleury (81/100), Genera (86/100), Invitae (83/100), Natera (85/100), Myriad Genetics (83/100) |
Moz Domain Authority 39/100 vs category average 41 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "A Mendelics é o primeiro e maior laboratório da América Latina focado em análise genômica. Conheça as nossas especialidades." (Meta description: 19 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, + Microdata, og:title, og:description, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is PT-only, limiting citation in English-language AI answers.
Detected tech stack: PHP, Nginx, WordPress, Ghost.
Social footprint: verified profiles on YouTube, Facebook, Instagram, LinkedIn, X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Mendelics?", Claude could identify the brand as of October 2026. Mendelics is a Brazilian genomics company based in São Paulo that offers genetic testing services, including whole exome and whole genome sequencing, to help diagnose rare and hereditary diseases. It operates its own sequencing lab in Brazil, which was notable for being one of th Best known for Being one of the first companies to offer large scale clinical genome and exome sequencing in Brazil.
When asked "Best brands similar to Mendelics?", Claude would recommend Mendelics as of October 2026. It's a well known name in Latin American genomics and would be relevant if someone asked about genetic testing companies in Brazil or the region.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Mendelics's main competitors in Healthcare: DASA (80/100), Fleury (81/100), Genera (86/100), Invitae (83/100), Natera (85/100).
Sources: Brand Analyzer scan
Mendelics offers genetic and genomic testing services, including exome sequencing, screening for recessive hereditary diseases, and testing for hereditary cancer. These services are intended to support diagnosis, prevention, and treatment decisions for patients, families, and healthcare professionals.
Sources: Mendelics official site
Mendelics is a Brazilian laboratory, founded in 2012 and based in São Paulo, that specializes in genomic analysis. It is described as the first and largest laboratory in Latin America dedicated to this field, offering genetic diagnostic services to patients, families, and healthcare professionals.
Sources: Mendelics official site
Mendelics has limited AI-search visibility, scoring 34/100 on Brand Analyzer's AI visibility composite (visibility 13, trust 53, recommendation 50). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Mendelics official site
Mendelics was founded in 2012. Mendelics operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Mendelics performs genomic analysis to support genetic diagnosis, prevention, and treatment of hereditary diseases and cancer. It offers exams such as exome sequencing, screening for recessive diseases, and testing for hereditary cancer, aiming to provide precise and accessible genetic diagnostics for patients and healthcare providers.
Sources: Mendelics official site
Mendelics scores 50/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Mendelics official site
Mendelics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Mendelics official site
Mendelics is known for being the first and largest genomics-focused laboratory in Latin America, specializing in advanced genetic testing such as exome analysis, recessive disease screening, and hereditary cancer testing.
Sources: Mendelics official site
Mendelics is used by patients and families seeking genetic diagnosis or screening for hereditary conditions, as well as healthcare professionals who order or interpret genomic tests for diagnosis, prevention, and treatment of hereditary diseases and cancer.
Sources: Mendelics official site
Mendelics scores 34/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Mendelics has a weak AI-visibility profile at 34/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is trust (53/100) and its weakest is visibility (13/100). It benefits from a Wikidata knowledge-graph entry, open access for AI crawlers (GPTBot, ClaudeBot, etc.) and machine-readable schema.org markup. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 39/100 and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Mendelics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Mendelics: Mehiläinen (80/100), MedTech Innovator (80/100), Mentalyc (80/100), Merck Millipore (80/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.